Original Research
Published on 22 Jul 2022
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization
in Radionuclide Therapy
![ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization](https://www.frontiersin.org/files/myhome article library/934446/934446_Thumb_400.jpg)
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.934446
- 1,246 views